Green Lumber Dietary Supplement recalled due to Undeclared prescription drug-Tadalafil, USA

United States

Green Lumber Holding, LLC ("Green Lumber") is issuing an updated consumer alert regarding counterfeit products falsely marketed as genuine Green Lumber products that may pose potential health risks. The affected product is distributed nationwide in the United States.

This update follows the U.S. Food and Drug Administration's (FDA) February 9 publication in its Enforcement Report referencing Green Lumber's original recall, which was initiated on August 28, 2025. The recall was issued in late August 2025 after FDA testing detected tadalafil, an undeclared prescription drug, in products labeled as Green Lumber. Tadalafil is not an ingredient in any authentic Green Lumber product. The February 9 Enforcement Report does not announce a new recall; it reflects publication of the previously announced August 28, 2025, recall.

Following the FDA's findings, Green Lumber conducted an internal investigation and determined that a company employee had misappropriated legitimate packaging and customer information to distribute counterfeit or adulterated products.

How to Identify the Counterfeit Recalled Product:
The counterfeit recalled product bears the Lot Number LOT308EXP03/28. This is the only lot number being recalled and is not an authentic Green Lumber lot number, and was used in connection with counterfeit products.

How to Identify Legitimate Green Lumber Products:
Authentic Green Lumber products that are presently being distributed bear the following lot numbers and are not the subject of the recall:
- LOTGL0130151EXP0926
- GL01EXP09/27
- LOT GL110725 EXP110727

Health Risks of Counterfeit Products:
The counterfeit versions may contain undeclared tadalafil. Because tadalafil is a prescription-only medication, individuals who take nitrates or certain prescription drugs for heart disease, blood pressure, or other conditions may be at risk of life-threatening side effects such as dangerously low blood pressure or other serious adverse events.

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-company-announcement-august-28-2025-recall-announcement